Biotech investors cap off record year in fundraising

Artificial Intelligence Is Transforming Biotechnology, Especially When It Comes To Innovations In Nitric Oxide

Biotech investors cap off record year in fundraising

AI drug discovery platform raises Series B funding

Global data and analysis on dealmaking, funding, and exits in private-market companies

European Biotech Investors Cap Off Record Year in Fundraising

How data is helping European VCs find their next hidden gems

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Biopharma Collaboration Is Key For Innovation

European Biotech Investors Cap Off Record Year in Fundraising